J Nat Prod. 2019 Mar 22;82(3):583-588. doi: 10.1021/acs.jnatprod.8b01036. Epub 2019 Feb 25.
The taccalonolides are a class of microtubule stabilizers that circumvent clinically relevant forms of drug resistance due to their unique mechanism of microtubule stabilization imparted by the covalent binding of the C-22-C-23 epoxide moiety to tubulin. A taccalonolide (8) with a fluorescein group attached with a linker at C-6 was generated, and biochemical and cell-based assays showed that it bound directly to tubulin and stabilized microtubules. This pharmacological probe has allowed, for the first time, a direct visualization of a taccalonolide binding to microtubules, verifying their cellular binding site. This C-6-modified taccalonolide showed potency comparable to the untagged compound in biochemical experiments; however, its potency was lower in cellular assays, presumably due to decreased cellular permeability. These studies provide a valuable tool to facilitate the further understanding of taccalonolide pharmacology and demonstrate that C-6 is a promising site for a linker to be added to this novel class of microtubule stabilizers for targeted drug delivery.
塔卡醇内酯是一类微管稳定剂,由于其通过 C-22-C-23 环氧化物部分与微管蛋白的共价结合赋予微管稳定的独特机制,因此可以规避由于临床相关形式的耐药性而产生的药物。生成了一种带有荧光团的带有连接子的 C-6 位连接的塔卡醇内酯(8),生物化学和基于细胞的测定表明它直接与微管蛋白结合并稳定微管。这种药理学探针首次允许直接观察塔卡醇内酯与微管的结合,从而验证了它们的细胞结合部位。与未标记的化合物相比,这种 C-6 修饰的塔卡醇内酯在生化实验中具有相当的效力;然而,在细胞测定中,其效力较低,可能是由于细胞通透性降低所致。这些研究为进一步了解塔卡醇内酯药理学提供了有价值的工具,并表明 C-6 是将该新型微管稳定剂类别的连接子添加到用于靶向药物递送的有希望的位点。